Shilpa Medicare Limited is preparing to seek US approval for its Ondansetron Extended-Release Injection (OERIS) within the next two years and is actively exploring licensing partners. The decision follows a successful Phase 3 trial in India, with..
.jpeg "Alkem Expands Hair Care Portfolio with Renocia Cyclical Therapy Kit")
Alkem launches Renocia cyclical therapy kit, a science-backed weekly hair nutrition system using vegetarian ingredients to boost hair growth, follicles strength, and reduce hair fall.
Panacea Biotec shares rise over 9% after completing Phase III enrollment for its dengue vaccine DengiALL, a potential first indigenous single-shot dengue vaccine in India.
Granules India announced today that U.S. based company, Granules Pharmaceuticals, Inc., has gotten probable designation of the U.S. Food and Drug Administration (FDA) on its generic amphetamine prolonged discharge pills that treat attention...
.png "Eli Lilly Buys Ventyx for $1.2B, Expanding NLRP3 Drug Portfolio")
Eli Lilly buys Ventyx as it builds its infiltration in inflammation-related diseases. The Indianapolis-based pharma giant reported today that it has initiated into a final deal to acquire Ventyx Biosciences. Ventyx Biosciences is a San Diego...
Dr. Lal PathLabs Limited today announced the launch of the Sovaaka Diagnostic Experience Centre in Gurugram, marking a major step in the evolution of preventive healthcare in India. The launch was graced by Haryana Chief Minister Nayab Singh...
Abbott launches Libre Assist at CES 2026, a smart Libre app feature using AI and CGM data to guide meal choices and predict glucose impact for people with diabetes.
Biocon Ltd announced Tuesday that its unit Biocon Biologics oncology biosimilars will expand with three new cancer therapies aimed at strengthening its presence in the global oncology market. With a regulatory filing, the company announced that...
Lupin Ltd announced today that its subsidiary, Lupin Manufacturing Solutions has entered into a longterm agreement with PolyPeptide Group AG. The joint venture will strengthen the global peptide-based active pharmaceutical ingredients supply...
Sun Pharmaceutical Industries has secured a major win after the Ahmedabad bench of the Customs, Excise and Service Tax Appellate Tribunal granted Sun Pharma CESTAT relief by setting aside a Rs 39 crore excise duty demand raised by tax authorities...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")